AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$3.76 USD
+0.13 (3.58%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.76 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $-0.16 | 20.73% |
Earnings Summary
For their last quarter, AbCellera Biologics (ABCL) reported earnings of -$0.17 per share, missing the Zacks Consensus Estimate of -$0.14 per share. This reflects a negative earnings surprise of 21.43%. Look out for ABCL's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 14.29%.
Earnings History
Price & Consensus
Zacks News for ABCL
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates
ABCL: What are Zacks experts saying now?
Zacks Private Portfolio Services